4-HYDROXYBUTYL N-((10S,23S)-10-ETHYL-18-FLUORO-10-HYDROXY-19-METHYL-5,9-DIOXO-8-OXA-4,15-DIAZAHEXACYCLO(14.7.1.02,14.04, 13.06,11.020,24)TETRACOSA-1,6(11),12,14,16,18,20(24)-HEPTAEN-23-YL)CARBAMATE
UNII R8KQ8U87ND
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-hydroxybutyl N-((10s,23s)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo(14.7.1.02,14.04, 13.06,11.020,24)tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl)carbamate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R8KQ8U87ND.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3054643-04-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H30FN3O7 OYMBRZPFKUVVIM-WRONEBCDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-hydroxybutyl N-((10s,23s)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo(14.7.1.02,14.04, 13.06,11.020,24)tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl)carbamate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.